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Formation of inner and outer cells of the mouse embryo distinguishes pluripotent inner cell mass (ICM) from differen-
tiating trophectoderm (TE). Carm1, which methylates histone H3R17 and R26, directs cells to ICM rather that TE. To
understand the mechanism by which this epigenetic modification directs cell fate, we generated embryos with in
vivo–labeled cells of different Carm1 levels, using time-lapse imaging to reveal dynamics of their behavior, and related
this to cell polarization. This shows that Carm1 affects cell fate by promoting asymmetric divisions, that direct one
daughter cell inside, and cell engulfment, where neighboring cells with lower Carm1 levels compete for outside positions.
This is associated with changes to the expression pattern and spatial distribution of cell polarity proteins: Cells with
higher Carm1 levels show reduced expression and apical localization of Par3 and a dramatic increase in expression of
PKCII, antagonist of the apical protein aPKC. Expression and basolateral localization of the mouse Par1 homologue,
EMK1, increases concomitantly. Increased Carm1 also reduces Cdx2 expression, a transcription factor key for TE
differentiation. These results demonstrate how the extent of a specific epigenetic modification could affect expression of
cell polarity and fate-determining genes to ensure lineage allocation in the mouse embryo.
INTRODUCTION
The first 3 d of mouse development involve the transition
from a single cell, the zygote, to the blastocyst, which con-
sists of a group of pluripotent cells destined to form the
embryo proper (inner cell mass [ICM]) surrounded by tro-
phectoderm (TE), whose derivatives form structures such as
the placenta. The precise mechanism governing the alloca-
tion of cells to inner and outer positions, to form ICM and
TE, respectively, remains unclear.
Epigenetic mechanisms are thought likely to be involved
in cell lineage allocation and specification (Shi and Wu,
2009). The posttranslational modification of histone (H) pro-
teins regulate the spatiotemporal expression patterns of
genes by altering chromatin structure, restricting or facili-
tating access for transcription factors that control gene ex-
pression. Consequently, varying levels of particular modifi-
cations can be associated with particular cell types. For
example, the methylation of H3K9me3 and H3K27me3 is
associated with the suppression of differentiation-associated
genes, and levels of these modifications are higher in ICM
cells than TE (Erhardt et al., 2003). In contrast, H3K4me3 and
acetylated H4K16 are markers of transcriptional activity and
tend to be associated with the expression of pluripotency
related genes Nanog, Sox2, and Oct4/Pou5f in ICM cells
(O’Neill et al., 2006). A role for epigenetic modification in the
allocation of cells to the different blastocyst lineages was first
suggested by the observation that the levels of H3R26me2
and H3R17me2 varied in four-cell stage blastomeres accord-
ing to their expected fate (Torres-Padilla et al., 2007). Specif-
ically, H3R26me2 levels were found to be lowest in blas-
tomeres contributing more to the TE surrounding the
blastocyst cavity and highest in blastomeres contributing
significantly more cells to the ICM and its surrounding polar
TE (Piotrowska-Nitsche et al., 2005; Torres-Padilla et al.,
2007). The enzyme that mediates the transfer of methyl
groups to arginine residues, including H3R26, is Carm1
(Chen et al., 1999; Schurter et al., 2001). Elevated expression
of Carm1 leads blastomeres to preferentially contribute to
the ICM (Torres-Padilla et al., 2007), indicating that this
particular epigenetic modification may be driving blas-
tomeres to a particular fate. The mechanism whereby blas-
tomeres with higher levels of H3R26/R17me2 contribute to
the ICM and those with lower H3R26/R17me2 levels to TE
lineages and whether such differences could culminate in
altered expression of particular genes that direct cell alloca-
tion and lineage determination, have remained unknown.
Inner and outer cell allocation is largely directed by
particular blastomere division orientations at the 8 –16-
and 16 –32-cell transitions (Barlow et al., 1972; Johnson and
Ziomek, 1981a,b; Pedersen et al., 1986; Dyce et al., 1987;
Fleming, 1987). Divisions that generate two outside cells are
described as symmetric and those generating one outside
and one inside cell, asymmetric. The ratio of asymmetric and
symmetric divisions and their spatial and temporal region-
alization can therefore serve to regulate cell contributions to
the ICM and TE (Fleming, 1987; Plusa et al., 2005; Bischoff et
al., 2008; Jedrusik et al., 2008; for review Zernicka-Goetz et al.,
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2009). Such divisions are preceded by apical–basal blas-
tomere polarization, which facilitates the generation of phe-
notypically distinct daughter cells from asymmetric divi-
sions: the outer cells are polar and inner cells, apolar
(Johnson and Ziomek, 1981a,b; Houliston et al., 1989). Sym-
metric division, on the other the hand, gives rise to two outer
cells that are phenotypically similar. Conserved cell polarity
molecules such as Par3, atypical protein kinase C (aPKC),
Jam1, and Par6 are key for setting up polarity in many
model systems (Goldstein and Macara, 2007). These mole-
cules localize apically during polarization of eight-cell blas-
tomeres of the mouse embryo (Thomas et al., 2004; Plusa et
al., 2005; Vinot et al., 2005). Moreover, their down-regulation
leads cells to preferentially adopt inside positions and de-
velop into ICM (Plusa et al., 2005). Accordingly, depletion of
aPKC demonstrated that it is required for symmetric divi-
sion in Xenopus embryos (Nakaya et al., 2000). More recent
studies have revealed that the TE-specific transcription fac-
tor Cdx2 (Niwa et al., 2005) also contributes to whether cells
divide symmetrically or asymmetrically, through effects on
the degree of cell polarization (Jedrusik et al., 2008). Up-
regulation of Cdx2 was associated with promoted apical
localization of aPKC, symmetric division and, conse-
quently, an increased contribution to the TE. However, none
of the studies carried out to date have shown how some
epigenetic modification can mediate cell lineage allocation in
the early mouse embryos.
Here we provide evidence that the expression levels of
Carm1 in individual blastomeres of the mouse embryo af-
fects cell polarity and, thus, cell fate. We show that increas-
ing levels of Carm1 alters the expression patterns of cell
polarity genes such as Par3, EMK1, aPKC, and PKCII and
the transcription factor Cdx2, which regulates the transition
away from pluripotency. These changes are associated with
cells being internalized, both by asymmetric divisions and as
a result of being engulfed by neighboring cells competing
for outside positions. These results lead us to propose a
model in which the extent of a particular epigenetic modi-
fication affects the expression levels of key cell polarity and
fate determining genes to regulate inner versus outer cell
allocation and lineage determination during development of
the preimplantation mouse embryo.
MATERIALS AND METHODS
Embryo Collection and Culture
Embryos were collected into M2 medium (4 mg/ml BSA) from superovulated
C57Bl6xCBA females mated with C57Bl6xCBA or H2B-EGFP (Hadjantonakis
and Papaioannou, 2004) males as described before (Bischoff et al., 2008).
Embryos were cultured in KSOM (4 mg/ml BSA) under paraffin oil in 5%
CO2 at 37.5°C.
mRNA Microinjection
mRNAs were transcribed in vitro using mMessage mMachine T3 polymerase
(Ambion, Austin, TX) from linearized pRN3P vector containing the following
constructs: Carm1.HA (full-length Carm1-coding sequence with a C-terminal
hemagglutinin [HA] tag; Chen et al., 1999), Carm1(E267Q).HA (as Carm1.HA,
but with an E267Q mutation generated with the QuickChange site-directed
mutagenesis kit; Stratagene, La Jolla, CA; Lee et al., 2002) and DsRed. RNA
was diluted in RNase-free H2O and working concentrations were as follows:
Carm1.HA and Carm1(E267Q).HA, 0.8–1.0 g/l; dsRed 0.05 g/l. All mi-
croinjections were carried out as previously described (Zernicka-Goetz et al.,
1997).
Time-Lapse Imaging and Analysis
Fluorescence and DIC Z-stacks of embryos from the zygote (24 h after human
chorionic gonadotropin [hCG]) or two-cell (44 h after hCG) to blastocyst stage
were collected on 15 focal planes every 15 min for96 and 72 h of continuous
embryo culture, respectively. The images were processed as described previ-
ously (Bischoff et al., 2008). All cells were followed in 4D using SIMI Biocell
software (http://www.simi.com/en/products/biocell/index.html/; Schnabel et
al., 1997): The 3D coordinates of every nucleus were taken every 2–3 frames,
including one frame before and one after cell cleavages. Between each of these
“fixed” points, cell movement was intercalated by SIMI Biocell software. Cell
behavior was defined using the position of daughter cells shortly after mitosis
and at the end of their cell cycle to determine whether they had moved from
or toward the outside, as in our previous study (Bischoff et al., 2008). If the
DIC images indicated a cell with a clear outside surface (e.g., highlighted in
Figure 2) and if there were no surrounding nuclei in the fluorescence images,
including consideration for nuclei above or below in the z-plane, then a cell
was defined as outer and vice versa for cells that did not meet these criteria.
By following every cell in the recording and using the DsRed fluorescence
signal at the two-cell stage to determine which blastomere had been injected
with Carm1 or Carm1(E267Q) mRNA, complete lineages of the behavior of all
cells up to the blastocyst stage were generated. This dataset allowed the
position, fate allocation and division orientation of all cells to be determined
individually.
Immunofluorescence Staining
Immunofluorescence staining was carried out as in Jedrusik et al. (2008).
Primary antibodies used were as follows: Cdx2 mouse monoclonal (BioGenex,
San Ramon, CA), 1:200 in PBS-Tween containing 3% wt/vol BSA; aPKC
rabbit polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA), 1:200; H3
dimethyl R26 rabbit polyclonal (Abcam, Cambridge, MA), 1:150; Carm1 rab-
bit polyclonal (Jackson ImmunoResearch Laboratories, West Grove, PA),
1:200; Par3 rabbit polyclonal (Millipore, Bedford, MA) 1:50; EMK1 rabbit
polyclonal (Hurov et al., 2004), 1:150. Secondary antibodies used were Alex-
aFluor 488–conjugated anti-mouse (Jackson ImmunoResearch Laboratories)
and AlexaFluor 488–conjugated anti-rabbit (Invitrogen, Carlsbad, CA), both
at 1:500.
For the time course of aPKC expression, embryos were collected 40 h after
hCG (midlate two-cell), cultured in KSOM and checked 3–4 times per day for
their progression. Embryos were fixed at mid-four-cell (approx. 50 h after
hCG), mid-eight-cell (6–7 h after 4–8-cell division), mid-16-cell (75 h after
hCG), and early blastocyst stages (82 h after hCG) and immunostained as
above. Confocal microscopy was performed using a 63/1.4 NA oil DIC
Plan-Apochromat lens on an upright Zeiss 510 Meta confocal microscope
(Thornwood, NY). Confocal sections were taken every 2 m through the
whole embryo and, where appropriate, the fluorescence signal was projected
using ImageJ software (http://rsb.info.nih.gov/ij/). To objectively measure
the fluorescence levels of proteins, individual cells were outlined manually in
Image J, and the intensity of the fluorescent signal was recorded for each
z-stack (on average, 7.4 per cell). These values were normalized against those
measured for DAPI (on average, 3.3 measurements per nucleus) and averaged
for each population of injected and noninjected cells in both experimental
(Carm1-injected) and control [Carm1(E267Q)-injected] embryos.
Quantitative RT-PCR
To investigate gene expression after Carm1 or Carm1(E267Q) mRNA injection,
25 embryos in which Carm1 or Carm1(E267Q) mRNAs were injected with that
of DsRed into one two-cell blastomere were disaggregated 6–7 h after blas-
tomere division to the eight-cell stage: Zonae were removed with 0.5% pro-
nase in PBS, the embryos were incubated in Ca2/Mg2-free M2 for 3–5 min,
separated into 2/8 blastomere pairs or 1/8 singlets by pipetting, and segre-
gated into groups based on the presence/absence of DsRed. For each of three
biological replicates, the 100 red and 100 non-red blastomeres collected were
placed into 10 l of RNA extraction buffer and snap-frozen until used in
quantitative RT-PCR (qRT-PCR). For time-course experiments, 50 zygotes,
early, mid, and late two-cell (approx. 18, 28, 34, and 40 h after hCG), early and
late four-cell (approx. 46 and 54 h after hCG), early, mid and late eight-cell (4,
7, or 10 h after eight-cell onset), early and late 16-cell embryos (4 and 10 h after
16-cell onset), and early blastocysts were used for RNA extraction and qRT-
PCR. For all samples, PicoPure RNA isolation kits (Arcturus Bioscience,
Mountain View, CA) were used for RNA extraction; samples were DNase
treated using the DNA-free kit (Ambion), and cDNA synthesis was per-
formed using SuperScript III Reverse Transcriptase (Invitrogen), including
Oligo(dT)20 and RNaseOUT Recombinant RNase Inhibitor. Products were
diluted 10-fold and 2 l was used per PCR. Reactions were performed in
technical triplicate for each primer pair (Supplemental Information) with
SYBR Green Master Mix (Applied Biosystems, Foster City, CA) in optical
96-well reaction plates on an AbiPrism 7000 Sequence Detection System.
Analysis and statistics were calculated in Excel (Microsoft, Redmond, WA),
and all normalization done against ActB expression using the following
equation: 2(Ct(ActB)  Ct(gene x)).
RESULTS
Carm1 Elevation Affects the Ratio of Asymmetric to
Symmetric Blastomere Divisions
Increased levels of Carm1 were reported to lead cells to
contribute preferentially to the ICM rather than TE lineage
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in mouse embryos (Torres-Padilla et al., 2007), but the mech-
anism behind the effect of Carm1 on lineage allocation re-
mained unknown. To address this question, we microin-
jected synthetic mRNA for either Carm1 or Carm1(E267Q),
which encodes an enzymatically inactive protein (Lee et al.,
2002; Torres-Padilla et al., 2007), into one late two-cell blas-
tomere to up-regulate Carm1 in just half of the embryo. To
identify this half, in all experiments DsRed mRNA was coin-
jected as a lineage marker. This approach led, on average, to
a 5.0-fold increase in the level of Carm1 transcript in the
progeny of Carm1 injected cells in comparison to their non-
injected counterparts. The overexpression of Carm1 was also
confirmed on the protein level (Supplemental Figure 1). To
understand how cells with higher Carm1 levels can change
their lineage allocation versus cells with lower levels of
Carm1, we used a live-imaging approach that allowed us to
track the positions and division orientations of all cells in
embryos as they develop to the blastocyst stage. To enable a
direct comparison of the cell behavior in these embryos with
that of previously reported unmanipulated, wild-type em-
bryos, we used the same methods of imaging and analysis as
established previously (Bischoff et al., 2008). DIC and fluo-
rescence sections were recorded on 15 focal planes at each
time point every 15 min for 72 h, during development
from the two-cell to blastocyst stages. Embryos were derived
from a H2B-enhanced green fluorescent protein (EGFP)
transgenic reporter line, which allowed visualization of their
nuclei via fluorescent chromatin.
We found that 88% (n  26, three independent experi-
ments) of embryos in our time-lapse recordings reached the
blastocyst stage, and all cells could be tracked in 61% (n 
14) of these embryos (the remaining seven embryos either
showed too weak an EGFP signal to confidently determine
the position of all their cells, or they moved from the field of
view during recordings). Similarly, in Carm1(E267Q) in-
jected control groups, the great majority (93%, n  31, three
independent experiments) of imaged embryos reached the
blastocyst stage, and all cells could be tracked in 12 of them
(as before, the remaining embryos were either not in the
field of view throughout imaging, or the EGFP signal was
too weak to track their cells. One embryo was eliminated as
it was asynchronous with other embryos imaged, reaching
46 cells before any of the others developed to the blastocyst
stage).
After imaging, the total number of cells per embryo in the
Carm1 group was, on average, 31.5 (1.0), of which 19.2
(4.9) were outer (TE) and 12.2 (4.9) were inner (ICM)
cells. The number of cells derived from the Carm1-injected
clone was similar to that derived from the noninjected
clone (Figure 1A). However, when we analyzed the con-
tribution of individual cells to the ICM, we found that the
significant majority (74.9%) were derived from the blas-
tomere in which the Carm1 level was increased (Figure
1A). The opposite was true when we analyzed the contri-
bution of clones to the TE. The proportion of outer cells
derived from blastomeres with artificially higher levels of
Carm1 was on average 35.4%; thus, the significant majority
(64.6%) of the TE was derived from the clone in which
Carm1 levels remained unchanged. This tendency was not
observed when Carm1(E267Q) mRNA was overexpressed in
place of Carm1: approximately half (47.8%) the progeny of
the Carm1(E267Q)-injected blastomere contributed to the
ICM and half (52.2%) to the TE (Figure 1B). Thus, elevated
expression of Carm1 in a two-cell blastomere leads its prog-
eny to contribute predominantly to the ICM (Student’s t test,
p  0.00022), in agreement with previous studies (Torres-
Padilla et al., 2007).
To understand whether differences in cell dynamics be-
tween the Carm1-injected and noninjected cells within the
same embryo accounted for the former’s more extensive
ICM allocation, we analyzed the behavior of all cells in 4D,
until their allocation to the ICM and TE at the early blasto-
cyst stage. Inner cells are largely generated through asym-
metric division of eight- and 16-cell blastomeres and the
division of inside cells from the 16-cell stage. To assess
whether Carm1 up-regulation was associated with a change
in the proportion of asymmetric/symmetric divisions, we
used Simi Biocell reconstructions to determine the division
orientation of the progeny of both two-cell blastomeres.
These were classified by scoring the positions of daughter
cells relative to each other and to the embryo surface one
frame before and one after their mitotic division in both DIC
and fluorescence images. This allowed the direct compari-
son of the proportions of asymmetric/symmetric divisions
between Carm1/Carm1(E267Q)-injected and noninjected
clones (Figure 1C, Supplemental Movie).
We found that during the 4th cleavage, the clone of cells in
which Carm1 levels were up-regulated took more asymmet-
ric divisions in comparison to the noninjected clone (on
average, 60.0 and 52.8%, respectively (p  0.0007; Figure
1D). Similarly, the proportion of asymmetric divisions taken
by the Carm1-injected clone was higher than that of the
Carm1(E267Q)-injected clone, which was 51.9% (p  0.0024).
In contrast, when we compared the proportion of asym-
metric divisions between noninjected clones of Carm1 and
Carm1(E267Q) groups, we found them to be statistically
equivalent (52.8 and 55.5%, respectively, p  0.43). Simi-
larly, the proportion of asymmetric divisions was statis-
tically equal in Carm1(E267Q)-injected and noninjected
blastomeres of the same embryos (52.3 and 55.1%, respec-
tively; p  0.097).
During 5th cleavage, we observed that the frequency of
symmetric divisions was higher than asymmetric ones in the
Carm1(E267Q)-injected clone (54.8 vs. 45.2%, respectively,
p  0.001) and the noninjected clone (54.6 vs. 45.4%, respec-
tively, p  0.001) in the same embryos, in accord with
previous studies (Bischoff et al., 2008; Jedrusik et al., 2008). In
contrast, cells with increased levels of Carm1 undertook
significantly more asymmetric (61.1%) than symmetric
(38.9%) divisions (p  0.001) during this cleavage period.
Indeed, the proportion of asymmetric divisions was signif-
icantly higher in cells with increased levels of Carm1 than in
the noninjected clone of the same embryos (47.6%, p 0.001)
and in Carm1(E267Q)-injected clones (45.2%, p  0.001).
These results provide evidence that elevation of Carm1 leads
cells to contribute more to the ICM through an increase in
the proportion of asymmetric over symmetric divisions, in
particular, during the 5th cleavage period.
Carm1 Leads to Cell Movement to the Inside
Compartment of the Embryo
We wondered whether the observed tendency for cells with
elevated Carm1 to contribute to the ICM resulted exclu-
sively from an effect on division orientation. Previous time-
lapse studies of intact, unmanipulated embryos demon-
strated that cell movements from the outside to the inside
compartment are rare, occurring in only 1.6% of all 16- and
32-cell blastomeres taken together (n  3168, from 66 em-
bryos; Bischoff et al., 2008). Reanalysis of this published data
shows that 22% (11/51) of these movements occurred dur-
ing the 16-cell stage and in the majority of cases (7/11), they
were from an inner to outer position rather than in the
opposite direction. Of the 40 movements observed during
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the 32-cell stage, the majority (82.5%) were from an inner to
an outer position.
To identify whether such cell repositioning happens after
Carm1 up-regulation, we scored the position (inner or outer)
of daughter cells both immediately after their mitotic divi-
sion and at the end of their cell cycle, to check whether this
had changed (Figure 2A; see Materials and Methods). This
revealed that in control, Carm1(E267Q) embryos, cell move-
Figure 1. Carm1 increases blastomere contribution to the ICM and frequency of asymmetric division. two-cell blastomeres of H2B-EGFP
embryos were injected with Carm1 (A) or Carm1(E267Q) (B) and DsRed mRNAs. After time-lapse microscopy, cells were scored as inner/outer
and DsRed positive and negative. Student’s t tests: *p  0.00022, ˆ p  0.00091. (C) H2B-EGFP–expressing embryos were injected as in A,
time-lapse imaged to the blastocyst stage and tracked using Simi Biocell software. DIC and GFP Z-stack images were used to determine
positions of blastomeres every 15 min. Examples where Carm1DsRed mRNAs were injected are shown. (D) Average proportions of
asymmetric and symmetric divisions during 4th and 5th cleavage for noninjected (top) and injected (bottom) clones in experimental (Carm1,
n  14) and control (E267Q, n  12) embryos. Error bars, SEM. Student’s t test: **p  0.001. Scale bar, 10 m.
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ment was observed in 2.3% of all cells (Figure 2, B and D;
n  576 when all 16- and 32-cell blastomeres are considered
together). Twenty-five percent (3/12) of these movements
occurred during the 16-cell stage, two of which were from an
inside to an outside position: one from a noninjected and the
other a Carm1(E267Q)-injected clone. Of the movements oc-
curring at the 32-cell stage, six of nine were from an inner to
an outer position, the noninjected and injected clones mak-
ing up similar proportions of these movements. Hence, cell
movement defined in these terms occurs as often as in
unmanipulated embryos and in similar “directions”
(Bischoff et al., 2008). In contrast, the frequency of cell move-
ment significantly increased in embryos in which Carm1 was
up-regulated, when compared with both Carm1(E267Q)-in-
jected and unmanipulated embryos: 8.7% of all cells were
observed to move in Carm1-injected embryos (n  672; 16-
and 32-cell blastomeres; Figure 2, C and D) and most of these
cell movements (77%, n  59) occurred during the 32-cell
stage. Strikingly, we found that cells with elevated levels of
Carm1 tended to move in the opposite direction to their
noninjected counterparts in the same embryos (i.e., from an
outer to inner position; Figure 2, B and D). Moreover, the
frequency of cell movement in the noninjected clone in-
dicated that cells of the noninjected clones moving in the
opposite direction might compensate for the behavior of
cells of the Carm1-injected clone. In agreement with this,
Figure 2. Carm1 leads to changes in the fre-
quency and direction of cell movement. two-cell
blastomeres of H2B-EGFP embryos were injected
with Carm1 (Carm1) or Carm1(E267Q) (E267Q)
and DsRed mRNAs, and their development was
tracked as in Figure 1. (A) Example illustrating
one 16-cell blastomere (red and purple asterisks)
dividing symmetrically (time-point 100) produc-
ing one daughter (red arrow) moving from an
outer to inner position, before dividing again
(time-point 142). Z-value indicates plane of view
(n  15), illustrating that the moving cell begins
at the top of the embryo, coming to occupy a
deeper position within the embryo in this plane
as well as in the X-Y plane. (B) Number and
direction of movements of noninjected (NonInj)
and injected () 16- and 32-cell-stage clones un-
der experimental (Carm1DsRed) and control
(Carm1(E267Q)DsRed) conditions. (C) Total num-
ber of cell movements in groups of embryos in-
jected with Carm1dsRed or Carm1(E267Q)DsRed
mRNAs at the two-cell stage. (D) Table summa-
rizing data in B and C. Clones are indicated as
positive () or negative (NonInj) for Carm1 or
Carm1(E267Q) for overexpression. Parentheses
indicate cumulative numbers of 16- and 32-cell
blastomeres (n) and % of these that alter their
position. Legend indicates outcomes of 2 tests
performed on data outlined in corresponding
colors.
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no extra cells were found in the ICM of Carm1 embryos
compared with Carm1(E267Q) embryos (p  0.69; Figure
1, A and B). Together with the analysis of division orien-
tation, these results provide evidence that elevation of
Carm1 leads cells to adopt ICM positions through both
increased frequency of asymmetric divisions and cell
movement.
Carm1 Elevation Affects the Expression and Distribution
of Par3 and EMK1 in a Reciprocal Manner
To gain further insight into the underlying reasons for our
observations on cell dynamics, we examined whether the
expression levels and/or distribution of polarity molecules
known to govern cell position might be affected by Carm1
up-regulation. We first focused on the cell polarity marker
Par3. To compare the expression levels of Par3 between cells
in which Carm1 was up-regulated and those in which it was
not in the same embryos, we performed qRT-PCR in three
biological samples of cDNA derived from 100 Carm1-in-
jected and 100 noninjected blastomeres of 25 disaggregated
eight-cell embryos. In control experiments, Carm1(E267Q)
mRNA replaced that of Carm1, as above. To determine
whether the disaggregation of blastomeres might have any
effect on Par3 transcript levels, we measured those of whole
and disaggregated (but otherwise unmanipulated) eight-cell
embryos at the same developmental time point. Low levels
of Par3 transcript were found in all eight-cell cDNA samples
(Figure 3A). There was no significant difference between
Par3 levels detected in cDNA derived from whole and dis-
aggregated eight-cell embryos (Figure 3A, Student’s t test,
p  0.35). Similarly, there was no significant difference in
these transcript levels between Carm1(E267Q)-injected cells
and their noninjected counterparts (Student’s t test, p 
0.62). In contrast, the levels of Par3 were 85% lower in the
Carm1-injected eight-cell clone than in its noninjected coun-
terpart, and, indeed, both control samples (two-way
ANOVA; p  0.001, Figure 3A). To determine the extent to
which this could also be seen at the protein level, we exam-
ined the distribution of Par3 by immunofluorescence. An
apical distribution of Par3 was detected in mid-eight-cell
blastomeres (Figure 3B), in agreement with one previous
report (Plusa et al., 2005) but in contrast to another (Vinot et
al., 2005). Furthermore, in agreement with the results of the
qRT-PCR experiments, these apical domains of Par3 ap-
peared attenuated in most (90%, 54/60) Carm1-injected blas-
tomeres (Figure 3, B and C). In agreement with this, when
we quantified the intensity of Par3 domains using Image J,
they were on average significantly less in the Carm1-injected
blastomeres compared with their noninjected counterparts
in the same embryos (p  0.01; Figure 3D). This was not
observed in Carm1(E267Q)-injected control embryos (Figure
3, E–G).
To determine whether the changes in cell behavior de-
scribed above could also reflect the organization of the ba-
solateral pole of eight-cell blastomeres, we examined the
distribution of the mammalian homologue of Par1, EMK1,
which localizes basolaterally at this stage (Vinot et al., 2005)
and is implicated in polarity and cell division regulation in
epithelial cells (Bohm et al., 1997). To compare the expression
levels of EMK1 between Carm1-injected and noninjected
clones in the same embryos, we carried out experiments
similar to the ones described for Par3. We found that EMK1
was detectable in all eight-cell and blastocyst cDNA samples
(Figure 4A). We could not find any significant differences in
EMK1 expression between Carm1(E267Q)-injected and non-
injected clones of the same embryos (Student’s t test, p 
0.8). In contrast we found that EMK1 transcript levels were
55% higher in Carm1-injected than in noninjected cells of the
same embryos (Figure 4A). Thus, EMK1 expression was
significantly higher when Carm1 levels were up-regulated
than in all other samples analyzed (two-way ANOVA, p 
0.013). To determine the extent to which this could also be
seen at the protein level, we examined the distribution of
EMK1 protein. Although EMK1 was present throughout the
cell, it showed a basolateral accumulation in eight-cell blas-
tomeres as described previously (Vinot et al., 2005). In none
of the 13 embryos expressing Carm1(E267Q) were we able to
detect any obvious difference in EMK1 distribution between
injected (n  52) and (n  52) noninjected clones (Figure 4,
E–G). However, the fluorescent signal of EMK1 appeared
stronger, particularly at the basolateral region, in the major-
Figure 3. Carm1 leads to decreased Par3 mRNA expression and
protein apicalization. (A) Separated eight-cell blastomeres injected
with Carm1 or Carm1(E267Q) and DsRed mRNAs at the two-cell
stage were pooled into noninjected (NonInj) and injected () sam-
ples used for qRT-PCR. Normalized averages of biological and
technical triplicate are shown. Blastocyst cDNA was used as a
positive control. As a disaggregation control, cDNA from 25 intact
eight-cell embryos and 25 disaggregated eight-cell embryos was
used in the same way. Normalized averages of biological dupli-
cate and technical triplicate are shown for these groups. Error
bars, SEM. Par3 transcripts were lower in Carm1-injected clones
than in Carm1(E267Q)-injected and both noninjected samples
(two-way ANOVA, *p  0.001). (B–G) Embryos treated as in A
were fixed at the eight-cell stage and immunostained for Par3.
Weaker Par3 domains (arrowheads) were associated with Carm1
injected clones (54/60 blastomeres, n  15 embryos), than non-
injected clones of the same embryos (arrows; B–D). This trend
was not observed in the 28 blastomeres of seven control embryos
(E–G). Scale bars, 20 m. Z value indicates plane of view (/n). (D
and G) Graphs indicating the mean fluorescence intensity of Par3
domains, measured for each cell in alternate Z-sections using
Image J and calculated for the Carm1/Carm1(E267Q)-injected and
noninjected cell populations. Error bars, SEM. Student’s t test,
**p  0.01.
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ity (75%, 36/48) of Carm1-injected blastomeres (n  48)
compared with their noninjected neighbors (n  48; Figure
4, B and C). When we quantified this, we found that the
intensity of the EMK1 signal was indeed significantly
greater in Carm1-injected blastomeres than in their nonin-
jected counterparts in the same embryos (p  0.024; Figure
4D). Together these results suggest that elevated expression
of Carm1 affects the expression and distribution of Par3 and
EMK1 in a reciprocal manner, a decrease in Par3 expression
and apical distribution being associated with an increase in
EMK1 expression and basolateral distribution. Thus, eleva-
tion of Carm1 leads to an alteration of the expression and
distribution of molecules known to regulate mammalian cell
polarity and associate with changes in division asymmetry
(Bohm et al., 1997; Plusa et al., 2005).
Carm1 Elevation Increases the Expression of the aPKC
Antagonist, PKCII
Because of the role demonstrated for the  isoform of aPKC
in affecting division orientation during mouse development
(Plusa et al., 2005) and pole size in Xenopus embryos (Chalm-
ers et al., 2005), we wondered whether the increased fre-
quency of asymmetric division and cell internalization asso-
ciated with Carm1 up-regulation is also associated with
changes in the expression or distribution of aPKC. To this
end, we first characterized the distribution of aPKC protein
from the two-cell stage to the late morula stage in normal
development (Figure 5). Initially, aPKC appears to be dis-
tributed uniformly at the cell cortex until the eight-cell stage
(Figure 5, A and B). However, this changes after compaction,
when aPKC distribution becomes distinctively apical at the
mid-eight-cell stage (Figure 5C) and is more evenly distrib-
uted over the apical cell membrane from the late eight-cell
stage onward; it also shows a detectable concentration at the
outer surface of the developing morula (Figure 5D). We also
quantified aPKC expression in total RNA extracts of intact,
unmanipulated embryos through developmental time. This
revealed a peak in aPKC levels concomitant with its change
in distribution at the eight-cell stage (Figure 5I).
To compare aPKC distribution between cells in which
Carm1 was elevated and their noninjected neighbors, mid-
eight-cell embryos expressing Carm1 and DsRed mRNAs in
the progeny of one two-cell blastomere were fixed and
stained with antibody specific to the kinase-containing C-
terminus of aPKC. This revealed that in 89% (85/96, n  24
embryos) of blastomeres with higher levels of Carm1, the
apical domains of aPKC appeared more concentrated than
in the noninjected neighboring blastomeres (Figure 5, K–N).
Such differences were not apparent between the injected and
noninjected clones of Carm1(E267Q) embryos (Figure 5, O
and P; n  11 embryos). Indeed, when we quantified the
intensities of aPKC domains, they were significantly higher
in the blastomeres in which Carm1 was elevated than their
counterparts with nonelevated Carm1 levels in the same
embryos (p  0.01; Figure 5M), a trend we did not observe
in Carm1(E267Q)-injected control embryos (Figure 3P). To
test this further, we analyzed aPKC transcript levels using
eight-cell cDNA samples as above: Levels in cells with ele-
vated Carm1 were 56% higher than in the noninjected cells
of the same embryos, a difference not seen between injected
and noninjected cells in Carm1(E267Q) embryos (Figure 5Q;
two-way ANOVA, p  0.0005).
In some respects, this was an unexpected result, as the
effect on Par3/EMK1 expression and distribution suggested
a “depolarizing” phenotype for Carm1 up-regulation. More-
over, down-regulation of aPKC promotes asymmetric di-
vision and cell internalization (Plusa et al., 2005), similar to
the effects described here for up-regulation of Carm1. How-
ever, although overexpression of aPKC is sufficient to in-
duce cell protrusion in Xenopus embryos, overexpression of
a truncated version of the protein, lacking the kinase do-
main, does not produce this phenotype (Chalmers et al.,
2005). This drew our attention to a previously reported
isoform, PKCII, showing 98% amino acid identity with
aPKC but lacking the kinase domain (Parkinson et al., 2004).
Because the interaction domains of these proteins are func-
tionally identical, PKCII is proposed to regulate the activity
of aPKC by competing for sites of activity in mammalian
epithelial cell culture (Parkinson et al., 2004). To date, there
have been no reports of whether a similar mechanism might
occur in the mouse embryo, so we wanted to examine
whether PKCII expression could be positively affected by
Figure 4. Carm1 leads to increased EMK1 mRNA levels and
changes to EMK1 protein distribution. (A) Separated eight-cell blas-
tomeres injected with Carm1 or Carm1(E267Q) and DsRed mRNAs at
the two-cell stage were pooled into noninjected (NonInj) and in-
jected () samples used for qRT-PCR. Normalized averages of
biological and technical triplicate are shown. Blastocyst cDNA was
used as a positive control. As a disaggregation control, cDNA from
25 intact eight-cell embryos and 25 disaggregated eight-cell em-
bryos was used in the same way. Normalized averages of biological
duplicate and technical triplicate are shown for these groups. Error
bars, SEM. EMK1 transcripts were higher in Carm1-injected clones
than Carm1(E267Q)-injected and both noninjected clones (two-way
ANOVA, *p  0.013). (B–G) Embryos treated as in A were fixed at
the eight-cell stage and immunostained for EMK1. Stronger EMK1
basolateral domains (arrows) were associated with Carm1-positive
clones (36/46 blastomeres, n  12 embryos) than the control clones
in the same embryos (B–D). This trend was not observed in 104
blastomeres analyzed from 13 control embryos (E–G). Scale bars, 20
m. Z value indicates plane of view (/n). (D and G) Graphs indi-
cating the mean fluorescence intensity of EMK1 domains, measured
for each cell in alternate Z-sections using Image J and calculated for
the Carm1/Carm1(E267Q)-injected and noninjected cell populations.
Error bars, SEM. Student’s t test, **p  0.024.
Carm1 and Pluripotency in the Mouse Embryo
Vol. 21, August 1, 2010 2655
Carm1 overexpression. Using primers specific for this par-
ticular isoform and lung cDNA as a positive control, we
found that expression of PKCII is indeed detectable in the
mouse embryo, although at lower levels than aPKC (Figure
5, I and J). This finding led us to analyze changes in PKCII
expression levels throughout preimplantation development,
which revealed a peak in its expression at the late eight-cell
stage (Figure 5I). To determine whether a change in PKCII
expression could be associated with Carm1 up-regulation,
we next compared the level of PKCII transcript in eight-cell
stage cells with higher levels of Carm1 with that of noninjected
clones in the same embryos. This revealed that PKCII levels
were 77-fold higher in cells in which Carm1 was elevated
(Figure 5Q). Such a difference was not seen between injected
and noninjected blastomeres in Carm1(E267Q) embryos.
Thus PKCII levels in Carm1-injected cells were significantly
higher than in all other samples (p 0.0032; Figure 6K). This
striking increase in PKCII expression observed upon Carm1
up-regulation could affect normal aPKC function at the
apical pole.
Carm1 Elevation Leads to Decreased Expression of Cdx2
The transcription factor Cdx2 is key for TE formation (Niwa
et al., 2005; Strumpf et al., 2005; Jedrusik et al., 2008; Nishioka
et al., 2009) and its down-regulation increases the probability
with which cells take asymmetric rather than symmetric
division (Jedrusik et al., 2008). We therefore wondered
whether Carm1 up-regulation affects the level of Cdx2 ex-
pression. To address this, we measured Cdx2 transcript lev-
els in cells in which Carm1 was up-regulated and compared
them with those of noninjected cells of the same embryos, as
above. This revealed that the expression of Cdx2 was 70%
lower in cells with higher levels of Carm1 (Figure 6A). This
was in contrast to the levels of Cdx2 observed between
injected and noninjected blastomeres in Carm1(E267Q) em-
bryos, which were statistically comparable. Thus, Carm1
overexpression results in a significant reduction in Cdx2
expression (two-way ANOVA, p  0.001).
Because Cdx2 expression shows heterogeneity at the
eight-cell stage, we extended the above analysis and exam-
ined the proportions of Cdx2-positive nuclei in blastomeres
with different levels of Carm1 at the eight-cell stage (Figure
6, B and C). From 19 embryos in which Carm1 was overex-
pressed, 60 eight-cell blastomeres were Cdx2-positive (Fig-
ure 6D). Of these, only 22 were derived from these cells in
which Carm1 was injected (2  4.28, p  0.039). Taken
together, these results provide evidence that Cdx2 is ex-
pressed to a lesser extent upon Carm1 up-regulation, but
also indicate that this association can be affected by the
endogenous variability in Cdx2, previously observed among
eight-cell blastomeres (Ralston and Rossant, 2008; Jedrusik et
al., 2008). This may parallel the natural heterogeneity in
Carm1-modified histone substrates observed at this time
(Torres-Padilla et al., 2007).
DISCUSSION
The divisions that internalize cells contribute to the first
differentiation event that separates ICM from TE in the
mouse embryo. Carm1 could play an important role in this
Normalized averages of biological and technical triplicate are
shown. Error bars, SEM. aPKC and PKCII transcripts were higher in
Carm1-injected clones than Carm1(E267Q)-injected and both nonin-
jected clones. Two-way ANOVA, *p  0.0005, **p  0.003.
Figure 5. Carm1 leads to increased expression of the aPKC an-
tagonist, PKCII. (A–H) aPKC protein in two-cell (n  5), 4-cell (n 
7), mid-eight-cell (n  28), and early 32-cell (n  8) embryos. (I)
aPKC and PKCII expression measured at several time points, plot-
ted as % of peak expression. (J) Normalized levels of aPKC and
PKCII transcripts measured by qRT-PCR using lung cDNA. Aver-
ages of biological duplicate and technical triplicate are shown. Error
bars, SEM. (K–P) Embryos treated as in A were examined for aPKC
at the eight-cell stage. Examples illustrate stronger apical aPKC
domains associated with Carm1-injected clones (outlined in red;
85/96 blastomeres, n  24 embryos) than the noninjected clones in
the same embryos (K–L). This trend was not observed in the 84
blastomeres from 11 control embryos (N and O). Scale bars, 20 m.
(M, P) Graphs indicating the mean fluorescence intensity of aPKC
domains, measured for each cell in alternate Z-sections using Image
J and calculated for the Carm1/Carm1(E267Q)-injected and nonin-
jected cell populations. Error bars, SEM. Student’s t test, **p  0.01.
(Q) Separated eight-cell blastomeres injected with Carm1 or
Carm1(E267Q) and DsRed mRNAs at the two-cell stage were pooled
into noninjected (NonInj) and injected () samples used for qRT-PCR.
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process, as its up-regulation was shown to lead to a higher
proportion of cells becoming ICM (Torres-Padilla et al.,
2007). The mechanism by which this is achieved and
whether differences in Carm1 levels could culminate in al-
tered expression of genes that direct cell division, and hence
cell allocation and lineage determination, have remained
unknown. Our study provides evidence that Carm1 expres-
sion influences cell polarity and the expression of genes that
affect the allocation of cells to the ICM versus TE lineages.
We find that higher levels of Carm1 lead to more asymmet-
ric divisions and cell internalization in association with re-
duced expression and diminished localization of Par3 api-
cally and increased expression of the basolateral marker
EMK1. Finally, our results suggest an involvement of the
aPKC antagonist, PKCII, and Cdx2 in this process.
The analysis of behavior and gene expression of cells with
differing levels of Carm1 developing side-by-side gives in-
sight into how endogenous heterogeneity in Carm1, and
differential modification of its targets such as H3R26/R17
(Torres-Padilla et al., 2007), contribute to the mechanisms of
inner cell allocation during preimplantation development.
Levels of Carm1 have been reported to vary in four-cell
blastomeres, showing the same tendencies as those of
H3R26me2 (Torres-Padilla et al., 2007), raising the possibility
that endogenous heterogeneity of this enzyme has an impact
on development, particularly in directing cells to the differ-
ent blastocyst lineages. The consequences of experimentally
elevating Carm1, we now report, add to these findings and
indicate that differences in Carm1 levels among cells could
influence cell dynamics. It will be of future interest to study
the effects of Carm1 elimination at these early stages. To date
this has only been achieved in zygotes injected with AMI-1,
an inhibitor of arginine methyltransferase activity that pref-
erentially targets Carm1 in vitro (Cheng et al., 2004). Such
injection led to developmental arrest after just one mitotic
division (Torres-Padilla et al., 2007). This experiment most
likely targeted maternally supplied Carm1, since loss of
zygotic Carm1 expression in Carm1/ embryos permitted
survival to perinatal stages (Yadav et al., 2003).
Blastomeres with higher levels of Carm1 up-regulate plu-
ripotency genes such as Nanog and Sox2 (Torres-Padilla et
al., 2007). This is likely to prime cells to become ICM,
whereas the changes in expression of cell polarity genes that
we report here would facilitate asymmetric division and cell
movement to fulfil this acquired potential. This suggests that
an inherent or induced molecular signature can override
signals from, or lead to an alteration in, cell position. In
keeping with the first of these possibilities, inner cells have
been demonstrated to retain inner identity while still having
a portion of their surface exposed to the perivitiline space
(PVS; Pederson et al., 1986). Thus, assessment of the propor-
tion of a cells’ surface exposed to the PVS may not always
accurately identify cells as inner or outer. Moreover, the cell
movement we observe here demonstrates that cell fate is not
yet fixed at this stage, in agreement with earlier reports
(Rossant and Vijh, 1980; Fleming, 1987; Suwinska et al.,
2008). The tracking of cells with differing levels of Carm1
side-by-side in the same embryos suggests that such cell
sorting may stem from conflicting influences between exter-
nal (positional) cues and the more inherent molecular sig-
nature of a cell. The inward movement of cells with higher
Carm1 levels and outward movement of their neighbors are
thus representative of cells’ plasticity with regard to adopt-
ing new positions within the embryo, depending on their
induced/inherent molecular signature. The observation that
cells in which Carm1 was not elevated tend to move out-
ward might illustrate compensation for inward movement
of cells with high Carm1 levels, so that the total number of
inside and outside remains similar, emphasizing the plastic-
ity of the embryo. Supportive of this idea are the results of
experiments in which Carm1 was overexpressed in the zy-
gote. Time-lapse analysis reveals that the average proportion
of asymmetric divisions taken during the 8–16-cell transition in
these embryos is greater than that of nonmanipulated embryos
at the same stage (p  0.001, Supplemental Figure 2A). A
similar, though weaker, trend is seen at the 16–32-cell stage
(p  0.041, Supplemental Figure 2A). Interestingly, this is
reflected in the average proportion of inner cells per blasto-
cyst analyzed—greater in embryos injected with Carm1 at
the zygote stage than in those injected at the two-cell stage
with Carm1 or Carm1(E267Q) (Supplemental Figure 2, B and
C). Together this adds weight to the observed effect of
increasing Carm1 levels on cell dynamics, which also further
suggest that reciprocal movement of unmanipulated cells
only compensate for changes in cell division pattern in par-
ticular contexts. Thus, intercellular variation in the levels
Figure 6. Carm1 leads to a down-regulation of Cdx2. (A) Sepa-
rated eight-cell blastomeres injected with Carm1 or Carm1(E267Q)
and DsRed mRNAs at the two-cell stage were pooled into nonin-
jected (NonInj) and injected () samples used for qRT-PCR. Nor-
malized averages of biological and technical triplicate are shown.
Error bars, SEM. Cdx2 transcripts were lower in Carm1-injected
clones than Carm1(E267Q)-injected and both noninjected clones.
Two-way ANOVA; *p 0.001. (B and C) Eight-cell embryos treated
as in A were fixed and immunostained for Cdx2. Six blastomeres in
the example are Cdx2-positive, one weakly so (arrowhead). Of
these, four derive from the noninjected clone. Scale bar, 20 m. (D)
Frequencies of Cdx2-positive nuclei in Carm1 overexpressing
(Carm1) and noninjected blastomeres (NonInj) from 19 embryos.
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(and activity) of Carm1 could be as influential as its presence
or absence. It is likely that when blastomeres with higher
levels of Carm1 develop alongside those in which Carm1
levels are lower, a sorting mechanism could relieve potential
conflicts between positional signals and cell identity result-
ing from, for example, the up-regulation of Nanog and Sox2
(Torres-Padilla et al., 2007). Such a mechanism could be
applicable to normal development in so far as endogenous
variation in the expression and/or activity of Carm1 (Torres-
Padilla et al., 2007) could account for patterns of cell behav-
ior (Fujimori et al., 2003; Piotrowska-Nitshe et al., 2005;
Bischoff et al., 2008).
The expression of several molecules regulating cell polar-
ity is changed upon up-regulation of Carm1. Par3 transcripts
are reduced by 84% at the eight-cell stage in Carm1-overex-
pressing clones and the apical distribution of its protein is
weaker than in noninjected blastomeres of the same em-
bryos, although not completely lost. The consequences for
this reduction could relate to the role of Par3 as a scaffold
protein: Its interaction with Par6 and aPKC is key to the
control of polarity and spindle orientation in different ani-
mal cells and manipulation of its expression is sufficient to
disrupt regulation of polarity and cell division (Hirose et al.,
2002). Conversely, its down-regulation in individual blas-
tomeres leads their progeny to contribute more cells to the
ICM (Plusa et al., 2005). Though it is clear, therefore, that
Par3 is involved in the onset of cell polarity, it is not clear
whether (or if so, how) Par3 regulates cell division. The
correlative evidence we present here would suggest this to
be possible, whether indirectly or otherwise, at the 8–16-cell
transition. The binding and activation of CDC42, a Rho-
family GTPase (Mackay and Hall, 1998) by Par3 could rep-
resent a mechanism through which this might take place,
potentially accounting for the effects on cell division and
movement we see in parallel to changes in Par3 distribution.
Because Par3 protein was still detected apically to some
extent in cells with higher levels of Carm1, molecules mak-
ing a basal contribution to cell polarity might also respond to
Carm1 and contribute to the phenotype we observe here.
In agreement with this, we find that Carm1 up-regulation
leads to a change in the expression and localization of
EMK1, which is localized basolaterally in eight-cell blas-
tomeres (Vinot et al., 2005 and this article). This change could
accord with a role for this molecule in positioning the spin-
dle and influencing cell–cell contacts, as observed in other
cell types (Bohm et al., 1997). Such functions might be me-
diated through its interaction with microtubule-associated
proteins (MAPs); the rat homologue, MARK-2, phosphory-
lates several MAPs in vivo and by so doing detaches them
from microtubules (Drewes et al., 1997). An increase in
EMK1 could therefore be partly responsible for the effects of
Carm1 up-regulation; it could destabilize microtubule dy-
namics and, combined with attenuation of Par3 at the apical
pole, randomize the axes of cell division at the eight-cell
stage, making divisions less likely to conform to structurally
imposed tendencies. The “inside” properties conferred by
high levels of Carm1 could then “push” cells to move in-
ward. Differences in cell adhesion, resulting from expression
of molecules such as E-cadherin (E-cad), could be involved
in such a scenario. This protein becomes enriched at regions
of cell–cell contact during compaction (Vestweber et al.,
1987), and although E-cad/ embryos undergo compaction
at the eight-cell stage, the increased cell–cell contacts are not
maintained and embryos do not develop to normal blasto-
cysts (Riethmacher et al., 1995). However, our studies do not
reveal any significant change in E-cad expression in response
to the overexpression of Carm1, either at the eight- or16-cell
stage (Supplemental Figure 3). Indeed, other mechanisms
could also feature in this process, such as the cytoskeletal
and shape changes recently suggested (Dard et al., 2009).
The observed strengthening of apical aPKC domains at
the mid-eight-cell stage along with increased aPKC mRNA
levels upon Carm1 up-regulation was unexpected. Overex-
pression of aPKC in Xenopus embryos results in an expan-
sion of blastomere apical domains (Chalmers et al., 2005). In
agreement with this, down-regulation of aPKC is associ-
ated with cell internalization (Plusa et al., 2005; Dard et al.,
2009), particularly when individual cells are targeted (Dard
et al., 2009). The similarity of this phenotype with that of
Carm1 overexpression makes the changes in aPKC expres-
sion and distribution we observe puzzling. However, it is
unclear whether the strengthening of aPKC domains and
increased mRNA levels are sufficient to bring about pheno-
typic alteration, especially because the changes in aPKC
distribution we observe are less dramatic than those associ-
ated with up-regulation of Cdx2 (Jedrusik et al., 2008). In-
deed, aPKC up-regulation appears to have no impact on
cell allocation and embryo development in the mouse, de-
spite the impact of its depletion in the same context (Dard et
al., 2009). However, there are important differences in the
normal distribution and function of these isoforms (Thomas
et al., 2004; Dard et al., 2009), which show 71% amino acid
sequence identity (Parkinson et al., 2004). Thus, changes in
aPKC could have consequences different from those of
aPKC. Bearing this in mind, our finding of a 77-fold in-
crease in the aPKC antagonist, PKCII, transcript levels upon
Carm1 elevation seem likely to be important in the interpre-
tation of our results. PKCII would compete with endoge-
nous aPKC for its binding sites. Furthermore, the time
course of aPKC and PKCII expression in embryos suggest
an endogenous mechanism for the regulation of aPKC
function. At least one target of aPKC is Par3: the binding
and phosphorylation of Par3 by aPKC, along with the asso-
ciation of Par6, is crucial to its function (Lin et al., 2000;
Hirose et al., 2002). Because the Par3 message and protein
appears to be reduced upon Carm1 elevation, any changes
in aPKC distribution may have less relevance. A similar
conclusion may be drawn from the finding that basolateral
EMK1 domains are strengthened in blastomeres with higher
levels of Carm1. Taken together, it seems unlikely that
Carm1 could be exerting its effects on division orientation
and polarity through aPKC alone.
It is also interesting to consider the relationship between
aPKC expression and Cdx2. Although Cdx2 mRNA is
present at low levels as early as the four-cell stage (Wang et
al., 2004; Jedrusik et al., 2008), nuclear Cdx2 protein appears
at the eight-cell stage and seems to be downstream of blas-
tomere polarization (Ralston and Rossant, 2008). However,
upon overexpression, Cdx2 is able to induce cell polariza-
tion, as evidenced by stronger aPKC domains (Jedrusik et
al., 2008). Here, we report that up-regulation of Carm1 leads
to a reduction in Cdx2 expression, on mRNA and protein
levels, at the eight-cell stage. Although this is in accord with
the effect of Carm1 up-regulation on cell fate and Nanog and
Sox2 expression (Torres-Padilla et al., 2007), it seems unlikely
to be a direct response, because the promoter of Cdx2 is not
enriched for Carm1 binding or H3R26/17 methylation, at
least in ES cells (Wu et al., 2009). Thus, it is tempting to
speculate a role for increased PKCII expression in the down-
regulation of aPKC, and hence Cdx2 mRNA and protein,
expression we observe here, in keeping with an inner, as
opposed to outer, cell identity. Indeed, expression of Cdx2 in
the inner cells is lost by the blastocyst stage (Dietrich and
Hiiragi, 2007; Ralston and Rossant, 2008; Jedrusik et al., 2008)
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and is essential to the specification and maintenance of TE
cell fate (Strumpf et al., 2005).
Although it is quite likely that the effect of Carm1 in
up-regulating pluripotency and down-regulating apical po-
larity of cells reflects its role in histone methylation and
transcriptional coactivation of nuclear receptors (Chen et al.,
1999), Carm1 also regulates many other processes (Wysocka,
2006; Kowenz-Leutz et al., 2010). As well as R17 and 26 on
histone H3, Carm1 targets H3 R128, 129, 131, and 134 and
H2A for methylation, in turn associated with up-regulation
of gene expression (Zhang and Reinberg, 2001). These mod-
ifications are generally considered as long-term epigenetic
marks, essential to the activation of specific gene expression
patterns (Lachner et al., 2004). However, Carm1 can also
cooperate with transcription factors such as p53 (An et al.,
2004) and p300 (Chen et al., 2000) and change chromatin
structure at particular promoters—putatively of genes such
as Nanog and Sox2 (Torres-Padilla et al., 2007)—and thereby
sustain pluripotency. This would prime cells with inner cell
properties, facilitating processes mediated by Par3 and
EMK1. Notwithstanding these possibilities, the results pre-
sented here bring us closer to linking an epigenetic mark to
the derivation of the ICM, most likely through the effect of
Par3 and EMK1 upon cell polarity, division mechanics and
movements.
ACKNOWLEDGMENTS
We are grateful to M.Z.-G. lab members for support and discussions and to
Kat Hadjantonakis (Sloan-Kettering, New York, NY) and Ginny Papaioannou
(Columbia University, New York, NY) for the reporter transgenic line. This
work was supported by the Wellcome Trust Senior Research Fellowship to
M.Z.-G. and MCR Studentship to D.-E.P.
REFERENCES
An, W., Kim, J., and Roeder, R. G. (2004). Ordered cooperative functions of
PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117,
735–748.
Barlow, P., Owen, D. A., and Graham, C. (1972). DNA synthesis in the
preimplantation mouse embryo. J. Embryol. Exp. Morphol. 27, 431–445.
Bischoff, M., Parfitt, D.-E., and Zernicka-Goetz, M. (2008). Formation of the
embryonic-abembryonic axis of the mouse blastocyst: relationships between
orientation of early cleavage divisions and pattern of symmetric/asymmetric
divisions. Development 135, 953–962.
Bohm, H., Brinkmann, V., Drab, M., Henske, A., and Kurzchalia, T. V. (1997).
Mammalian homologues of C. elegans PAR-1 are asymmetrically localized in
epithelial cells and may influence their polarity. Curr. Biol. 7, 603–606.
Chalmers, A. D., Pambos, M., Mason, J., Lang, S., Wylie, C., and Papalopulu,
N. (2005). aPKC, Crumbs3 and Lgl2 control apicobasal polarity in early
vertebrate development. Development 132, 977–986.
Chen, D., Huang, S. M., and Stallcup, M. R. (2000). Synergistic, p160 coacti-
vator-dependent enhancement of estrogen receptor function by CARM1 and
p300. J. Biol. Chem. 275, 40810–40816.
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S. M., Schurter, B. T., Aswad,
D. W., and Stallcup, M. R. (1999). Regulation of transcription by a protein
methyltransferase. Science 284, 2174–2177.
Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., and
Bedford, M. T. (2004). Small molecule regulators of protein arginine methyl-
transferases. J. Biol. Chem. 279, 23892–23899.
Dard, N., Le, T., Maro, B., and Louvet-Valle´e, S. (2009). Inactivation of
aPKClambda reveals a context dependent allocation of cell lineages in pre-
implantation mouse embryos. PLoS One 4, e7117.
Dietrich, J. E., and Hiiragi, T. (2007). Stochastic patterning in the mouse
pre-implantation embryo. Development 134, 4219–4231.
Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E. M., and Mandelkow, E.
(1997). MARK, a novel family of protein kinases that phosphorylate micro-
tubule-associated proteins and trigger microtubule disruption. Cell 89, 297–
308.
Dyce, J., George, M., Goodall, H., and Fleming, T. P. (1987). Do trophectoderm
and inner cell mass cells in the mouse blastocyst maintain discrete lineages?
Development 100, 685–698.
Erhardt, S., Lyko, F., Ainscough, J. F., Surani, M. A., and Paro, R. (2003).
Polycomb-group proteins are involved in silencing processes caused by a
transgenic element from the murine imprinted H19/Igf2 region in Drosoph-
ila. Dev. Genes Evol. 213, 336–344.
Fleming, T. P. (1987). A quantitative analysis of cell allocation to trophecto-
derm and inner cell mass in the mouse blastocyst. Dev. Biol. 119, 520–531.
Goldstein, B., and Macara, I. G. (2007). The PAR proteins: fundamental
players in animal cell polarization. Dev. Cell 13, 609–622.
Hadjantonakis, A. K., and Papaioannou, V. E. (2004). Dynamic in vivo imag-
ing and cell tracking using a histone fluorescent protein fusion in mice. BMC
Biotechnol. 4, 33.
Hirose, T., et al. (2002). Involvement of ASIP/PAR-3 in the promotion of
epithelial tight junction formation. J. Cell Sci. 115, 2485–2495.
Houliston, E., Pickering, S. J., and Maro, B. (1989). Alternative routes for the
establishment of surface polarity during compaction of the mouse embryo.
Dev. Biol. 134, 342–350.
Hurov, J. B., Watkins, J. L., and Piwnica-Worms, H. (2004). Atypical PKC
phosphorylates par-1 kinases to regulate localization and activity. Curr. Biol.
14, 736–741.
Jedrusik, A., Parfitt, D. E., Guo, G., Skamagki, M., Grabarek, J. B., Johnson,
M. H., Robson, P., and Zernicka-Goetz, M. (2008). Role of Cdx2 and cell
polarity in cell allocation and specification of trophectoderm and inner cell
mass in the mouse embryo. Genes Dev. 22, 2692–2706.
Johnson, M. H., and Ziomek, C. A. (1981a). Induction of polarity in mouse
8-cell blastomeres: specificity, geometry, and stability. J. Cell Biol. 91, 303–308.
Johnson, M. H., and Ziomek, C. A. (1981b). The foundation of two distinct cell
lineages within the mouse morula. Cell 24, 71–80.
Kowenz-Leutz, E., Pless, O., Dittmar, G., Knoblich, M., and Leutz, A. (2010).
Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and
SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J.
29, 1105–1115.
Lachner, M., Sengupta, R., Schotta, G., and Jenuwein, T. (2004). Trilogies of
histone lysine methylation as epigenetic landmarks of the eukaryotic genome.
Cold Spring Harb. Symp. Quant. Biol. 69, 209–218.
Lee, Y. H., Koh, S. S., Zhang, X., Cheng, X., and Stallcup, M. R. (2002). Synergy
among nuclear receptor coactivators: selective requirement for protein meth-
yltransferase and acetyltransferase activities. Mol. Cell Biol. 22, 3621–3632.
Lin, D., Edwards, A. S., Fawcett, J. P., Mbamalu, G., Scott, J. D., and Pawson,
T. (2000). A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1
and aPKC signalling and cell polarity. Nat. Cell Biol. 2, 540–547.
Mackay, D. J., and Hall, A. (1998). Rho GTPases. J. Biol. Chem. 273, 20685–
20688.
Nakaya, M., Fukui, A., Izumi, Y., Akimoto, K., Asashima, M., and Ohno, S.
(2000). Meiotic maturation induces animal-vegetal asymmetric distribution of
aPKC and ASIP/PAR-3 in Xenopus oocytes. Development 127, 5021–5031.
Nishioka, N., et al. (2009). The Hippo signaling pathway components Lats and
Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner
cell mass. Dev. Cell 16, 398–410.
Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R.,
and Rossant, J. (2005). Interaction between Oct3/4 and Cdx2 determines
trophectoderm differentiation. Cell 123, 917–929.
O’Neill, L. P., VerMilvea, M. D., and Turner, B. M. (2006). Epigenetic charac-
terization of the early embryo with a chromatin immunoprecipitation proto-
col applicable to small cell populations. Nat. Genet. 38, 835–841.
Parkinson, S. J., Le Good, J. A., Whelan, R. D., Whitehead, P., and Parker, P. J.
(2004). Identification of PKCzetaII: an endogenous inhibitor of cell polarity.
EMBO J. 23, 77–88.
Pedersen, R. A., Wu, K., and Bałakier, H. (1986). Origin of the inner cell mass
in mouse embryos: cell lineage analysis by microinjection. Dev. Biol. 117,
581–595.
Piotrowska-Nitsche, K., Perea-Gomez, A., Haraguchi, S., and Zernicka-Goetz,
M. (2005). Four-cell stage mouse blastomeres have different developmental
properties. Development 132, 479–490.
Plusa, B., Frankenberg, S., Chalmers, A., Hadjantonakis, A. K., Moore, C. A.,
Papalopulu, N., Papaioannou, V. E., Glover, D. M., and Zernicka-Goetz, M.
(2005). Downregulation of Par3 and aPKC function directs cells towards the
ICM in the preimplantation mouse embryo. J. Cell Sci. 118, 505–515.
Carm1 and Pluripotency in the Mouse Embryo
Vol. 21, August 1, 2010 2659
Ralston, A., and Rossant, J. (2008). Cdx2 acts downstream of cell polarization
to cell-autonomously promote trophectoderm fate in the early mouse embryo.
Dev. Biol. 313, 614–629.
Riethmacher, D., Brinkmann, V., and Birchmeier, C. (1995). A targeted muta-
tion in the mouse E-cadherin gene results in defective preimplantation de-
velopment. Proc. Natl. Acad. Sci. USA 92, 855–859.
Rossant, J., and Vijh, K. M. (1980). Ability of outside cells from preimplanta-
tion mouse embryos to form inner cell mass derivatives. Dev. Biol. 76,
475–482.
Schnabel, R., Hutter, H., Moerman, D., and Schnabel, H. (1997). Assessing
normal embryogenesis in Caenorhabditis elegans using a 4D microscope: vari-
ability of development and regional specification. Dev. Biol. 184, 234–265.
Schurter, B. T., Koh, S. S., Chen, D., Bunick, G. J., Harp, J. M., Hanson, B. L.,
Henschen-Edman, A., Mackay, D. R., Stallcup, M. R., and Aswad, D. W.
(2001). Methylation of histone H3 by coactivator-associated arginine methyl-
transferase 1. Biochemistry 40, 5747–5756.
Shi, L., and Wu, J. (2009) Epigenetic regulation in mammalian preimplanta-
tion embryo development [Review]. Reprod. Biol. Endocrinol. 7, 59, 133–144.
Strumpf, D., Mao, C. A., Yamanaka, Y., Ralston, A., Chawengsaksophak, K.,
Beck, F., and Rossant, J. (2005). Cdx2 is required for correct cell fate specifi-
cation and differentiation of trophectoderm in the mouse blastocyst. Devel-
opment 132, 2093–2102.
Suwinska, A., Czolowska, R., Ozdzenski, W., and Tarkowski, A. K. (2008).
Blastomeres of the mouse embryo lose totipotency after the fifth cleavage
division: expression of Cdx2 and Oct4 and developmental potential of inner
and outer blastomeres of 16- and 32-cell embryos. Dev. Biol. 322, 133–144.
Thomas, F. C., Sheth, B., Eckert, J. J., Bazzoni, G., Dejana, E., and Fleming, T. P.
(2004). Contribution of JAM-1 to epithelial differentiation and tight-junction
biogenesis in the mouse preimplantation embryo. J. Cell Sci. 117, 5599–5608.
Torres-Padilla, M. E., Parfitt, D. E., Kouzarides, T., and Zernicka-Goetz, M.
(2007). Histone arginine methylation regulates pluripotency in the early
mouse embryo. Nature 445, 214–218.
Vinot, S., Le, T., Ohno, S., Pawson, T., Maro, B., and Louvet-Vallee, S. (2005).
Asymmetric distribution of PAR proteins in the mouse embryo begins at the
8-cell stage during compaction. Dev. Biol. 282, 307–319.
Wu, Q., Bruce, A. W., Jedrusik, A., Ellis, P. D., Andrews, R. M., Langford,
C. F., Glover, D. M., and Zernicka-Goetz, M. (2009). CARM1 is required in ES
cells to maintain pluripotency and resist differentiation. Stem Cells 27, 2637–
2645.
Vestweber, D., Gossler, A., Boller, K., and Kemler, R. (1987). Expression and
distribution of cell adhesion molecule uvomorulin in mouse preimplantation
embryos. Dev. Biol. 124, 451–456.
Wysocka, J. (2006). Identifying novel proteins recognizing histone modifica-
tions using peptide pull-down assay. Methods 40, 339–343.
Yadav, N., Lee, J., Kim, J., Shen, J., Hu, M. C., Aldaz, C. M., and Bedford, M. T.
(2003). Specific protein methylation defects and gene expression perturbations
in coactivator-associated arginine methyltransferase 1-deficient mice. Proc.
Natl. Acad. Sci. USA. 100, 6464–6468.
Zernicka-Goetz, M., Pines, J., McLean Hunter, S., Dixon, J. P., Siemering, K. R.,
Haseloff, J., and Evans, M. J. (1997). Following cell fate in the living mouse
embryo. Development. 124, 1133–1137.
Zernicka-Goetz, M., Morris, S. A., and Bruce, A. W. (2009). Making a firm
decision: multifaceted regulation of cell fate in the early mouse embryo. Nat.
Rev. Genet. 10, 467–477.
Zhang, Y., and Reinberg, D. (2001). Transcription regulation by histone meth-
ylation: interplay between different covalent modifications of the core histone
tails. Genes Dev. 15, 2343–2360.
D.-E. Parfitt and M. Zernicka-Goetz
Molecular Biology of the Cell2660
